| Basics |
|
SILO PHARMA INC
|
| IPO Date: |
January 8, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$5.84M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.07 | 4.62%
|
| Avg Daily Range (30 D): |
$0.02 | 3.23%
|
| Avg Daily Range (90 D): |
$0.02 | 3.95%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.63M |
| Avg Daily Volume (30 D): |
.22M |
| Avg Daily Volume (90 D): |
.73M |
| Trade Size |
| Avg Trade Size (Sh.): |
213 |
| Avg Trade Size (Sh.) (30 D): |
357 |
| Avg Trade Size (Sh.) (90 D): |
295 |
| Institutional Trades |
| Total Inst.Trades: |
0 |
| Avg Inst. Trade: |
$M |
| Avg Inst. Trade (30 D): |
$M |
| Avg Inst. Trade (90 D): |
$M |
| Avg Inst. Trade Volume: |
M |
| Avg Inst. Trades (Per Day): |
0 |
| Market Closing Trades |
| Avg Closing Trade: |
$M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-.12
|
|
$-.23
|
|
Diluted EPS
|
$-.12
|
|
$-.23
|
|
Revenue
|
$ .02M
|
$
|
$ .02M
|
|
Gross Profit
|
$ M
|
$
|
$ .02M
|
|
Net Income / Loss
|
$ -1.11M
|
$ -1.2M
|
$ -1.03M
|
|
Operating Income / Loss
|
$ -1.15M
|
$
|
$ -1.09M
|
|
Cost of Revenue
|
$ .02M
|
$
|
$ M
|
|
Net Cash Flow
|
$
|
$
|
$ M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Sep 15, 2022:
1:50
|
|
|
|